DCB in PCI: Adjunctive Therapy or Standard of Care?

Published: 14 February 2022

  • Views:

    Views Icon 28630
  • Likes:

    Heart Icon 7

Overview

Learn more about the origins and science behind the DCB technology, the important clinical data supporting DCB use in the coronary arteries, existing and emerging treatment indications through videos, interviews and panel discussions with renowned faculty from highly ranked institutions.

This programme is supported by: Medtronic

Key Learning Objectives

  • To discuss the origins and science behind the DCB technology, its current and potential areas of application in various clinical scenarios, and emphasize the benefits of DCB technology vs DES and Paclitaxel vs Limus.
  • To emphasize the importance of vessel preparation, algorithms of optimal therapy delivery and criteria used for immediate results evaluation.
  • To highlight the DCB Clinical Program, understanding the clinical benefits and safety of paclitaxel DCBs, and its relevance to your daily practice

Target Audience

  • Interventional Cardiologists
  • General Cardiologists
  • Allied Healthcare Professionals

More from this programme

Part 1

Science of DCB

In episode, both physicians will discuss the origins behind the drug-coated balloons (DCBs) technology. One of the fathers of DCB technology Prof Bruno Scheller, will share a fascinating story about how a bit of luck and solid experimentation had a tremendous impact on what is now seen as a very exciting new era in cardiology. Followed by episode 2, Prof Scheller and Dr Tunev delve into an important discussion around the benefits of DCBs vs DES and PTX vs Limus, providing insights on DCB mechanisms of action and predictors of long-tern efficacy. Questions 1: How do DCBs work in the vessel? Question 2: What are the benefits of DCB vs DES? Question 3: What is the difference between the two drugs in the context of DCB?

Part 2

DCB: Role of Predilatation and dissection assessment

This episode sheds light on very important steps of the DCB-alone PCI - lesion preparation and dissection assessment. Prof Scheller and Dr Mylotte discuss how their practice has evolved in terms of preparing the lesion for treatment with a DCB, and share their recommendations how to manage different types of dissections. In episode 2, we learn the differences between acute results for scaffold vs no scaffold, what are the acceptable acute results and why no perfect results of DCB could be accepted and much more. Lastly, in episode 3, we learn how to integrate OCT, IVUS and FFR into decision taking as well as the importance of aggressive vessel preparation and what lesions to exclude from DCB.

Faculty Biographies

Darren Mylotte

Darren Mylotte

Consultant Cardiologist

Dr Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands.

Dr Mylotte specializes in general cardiology, and has subspecialty interests in the assessment, diagnosis and treatment of ischaemic heart disease, valvular heart disease

 

View full profile
Bruno Scheller

Bruno Scheller

Dr Bruno Scheller studied medicine at the University of Saarland, Germany, from 1988 til 1994. Since 1994 he has been working as a physician at the clinic for internal medicine III,, University Hospital of Saarland, Homburg/Saar, Germany, where he is a consultant for internal medicine, cardiology, and intensive care. He is a full professor for Clinical and Experimental Interventional Cardiology at the Medical School of the University. 

View full profile